Justice Dept. Says Generics Maker Ranbaxy Forged Documents

In a development unlikely to improve skittish patients’ views of generic drugs, Indian generics maker Ranbaxy Laboratories is being probed for allegedly forging documents involved in an existing investigation into the quality of its drugs. The Justice Department earlier this month filed a motion in federal court in Maryland alleging that Ranbaxy falsified the documents, and [...]